Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jan;172(1):16-20.
doi: 10.1136/ewjm.172.1.16.

Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention

K H Seal  1 , K C Ochoa, J A Hahn, J P Tulsky, B R Edlin, A R Moss
Affiliations

Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention

K H Seal et al. West J Med. 2000 Jan.

Erratum in

  • West J Med 2000 Mar;172(3):193

Abstract

Objective: To compare the demographic characteristics and risk behaviors for hepatitis B infection among injection drug users younger than 30 years with those aged 30 or older and to evaluate participants' knowledge, attitudes, and experiences of infection, screening, and vaccination against hepatitis B virus.

Design: A systematic sample of injection drug users not currently in a treatment program were recruited and interviewed at needle exchange programs and community sites.

Participants: 135 injection drug users younger than 30 years and 96 injection drug users aged 30 or older.

Results: Injection drug users younger than 30 were twice as likely as drug users aged 30 or older to report having shared needles in the past 30 days (36/135 [27%] vs 12/96 [13%]). Injection drug users younger than 30 were also twice as likely to report having had more than two sexual partners in the past 6 months (80/135 [59%] vs 29/96 [30%]). Although 88 of 135 (68%) young injection drug users reported having had contact with medical providers within the past 6 months only 13 of 135 (10%) had completed the hepatitis B vaccine series and only 16 of (13%) perceived themselves as being at high risk of becoming infected with the virus.

Conclusion: Few young injection drug users have been immunized even though they have more frequent contact with medical providers and are at a higher risk for new hepatitis B infection than older drug users. Clinicians caring for young injection drug users and others at high risk of infection should provide education, screening, and vaccination to reduce an important source of hepatitis B infection.

PubMed Disclaimer

Comment in

References

    1. Centers for Disease Control and Prevention. Protection against viral hepatitis: recommendations of the immunization practices advisory committee (ACIP). MMWR Morb Mortal Wkly Rep 1990;39(RR-2):5-22.
    1. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the immunization practices advisory committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40(RR-13):1-25. - PubMed
    1. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92. - PubMed
    1. Levine OS, Vlahov D, Koehler J, et al. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol1995;142:331-341. - PubMed
    1. Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med 1982;97:362-366. - PubMed

Publication types